Vinge advises Ellevio in connection with its acquisition of Markbygden Net AB, a modern transmission network which connects Europe’s largest wind farm cluster Markbygden 1101 outside Piteå in northern Sweden, from Svevind and Enercon.

Ellevio is one of Sweden’s biggest distribution network operators and, with the acquisition, Ellevio is establishing itself in Sweden’s northern electricity region for the first time, strengthening its role in accelerating Sweden’s journey towards net-zero emissions by 2045. Ellevio owns Markbygden Net AB as of 20 September 2023.

Vinge’s team consisted of partner in charge Peter Sundgren (Energy/M&A) together with Desirée Hagenfeldt, Robin Sultani and Eskil Nyström (M&A), Johan Cederblad and Madelene Andersson (Environment), Karolina Cohrs (Real estate), Mathilda Persson and Alva Skott (Commercial Agreements and IT), Mario Saad and Carl Lexenberg (Commercial Agreements), Daniel Wendelsson (Public procurement and FDI), Carl Johan af Petersens and Andrea Rökaas (Regulatory), Daniel Prawitz (Construction), Arvid Axelryd (IP), Amelia Rihs (Employment), David Flodin (Financial arrangements), Julia Löfqvist (Compliance) Gabriella Balbo and Jessica Henning (VDR).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025